Showing 3601-3610 of 20433 results for "".
- Upadacitinib Linked with Improvement for Hand Eczema in Patients with Atopic Dermatitishttps://reachmd.com/news/updacitinib-shows-promise-for-ad-and-hand-eczema-in-trial/2462198/Results from a new study suggest that upadacitinib is efficacious for the treatment of hand eczema (HE) and atopic dermatitis (AD) in patients with AD. The study authors, publishing in Contact Dermatitis, included a total of 38 patients in the observational cohort analysis (32 of
- 187 New Genetic Variants Linked to Prostate Cancer Found in Largest, Most Diverse Study of Its Kindhttps://reachmd.com/news/187-new-genetic-variants-linked-to-prostate-cancer-found-in-largest-most-diverse-study-of-its-kind/2456691/A globe-spanning scientific team has compiled the most comprehensive list of genetic variants associated with prostate cancer risk — 451 in all — through a whole-genome analysis that ranks as the largest and most diverse investigation into prostate cancer genetics yet. The research, led by the
- Fractional COVID-19 Booster Vaccines Produce Similar Immune Response as Full-Doseshttps://reachmd.com/news/fractional-covid-19-booster-vaccines-produce-similar-immune-response-as-full-doses/2456705/Reducing the dose of a widely used COVID-19 booster vaccine produces a similar immune response in adults to a full-dose with fewer side effects, according to a new study. The research, led by Murdoch Children's Research Institute (MCRI) and the National Centre for Communicable D
- Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Methttps://reachmd.com/news/microbot-medical-announced-positive-results-of-its-glp-pivotal-pre-clinical-study-where-all-study-objectives-were-met/2456694/BRAINTREE, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announces the successful completion of its GLP pivotal pre-clinical study, done under
- New Doctors Just Aren't That Interested in Geriatricshttps://reachmd.com/news/new-doctors-just-arent-that-interested-in-geriatrics/2456712/Doctors specializing in care for older adults are increasingly in demand as the country
- New Studies Inform Best Practices for Pelvic Organ Prolapsehttps://reachmd.com/news/new-studies-inform-best-practices-for-pelvic-organ-prolapse/2456699/For patients with uterine prolapse, a traditional technique showed superiority, while vaginal estrogen cream failed to improve outcomes for vaginal apical prolapse repair in two new studies published in JAMA.“Approximately one in five women will undergo surg
- Early Indicators of Multiple Sclerosis Evident 5 Years Before Diagnosis, Reveals Recent Studyhttps://reachmd.com/news/early-indicators-of-multiple-sclerosis-evident-5-years-before-diagnosis-reveals-recent-study/2456696/A recent study has revealed five early symptoms of multiple sclerosis that can be identified five years prior to the diagnosis. According to Mayo Clinic, “Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system).
- U of M Study Finds Metformin Reduces COVID-19 Viral Load, Viral Reboundhttps://reachmd.com/news/u-of-m-study-finds-metformin-reduces-covid-19-viral-load-viral-rebound/2462939/MINNEAPOLIS/ST. PAUL (5/02/2024) — A team of University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, can decrease the amount of COVID-19 virus in the body and lower the chances of the virus coming back strongly a
- Children Born to Mothers with Pregnancy Complications Face Higher Heart Riskshttps://reachmd.com/news/children-born-to-mothers-with-pregnancy-complications-face-higher-heart-risks/2457156/Women who develop high blood pressure or diabetes in the course of pregnancy are more likely to give birth to children who develop conditions that may compromise their own heart health at a young age, scientists reported on Monday.By the time they are 12 years old, these chi
- Variation in Evaluation and Management of Febrile Infants 61 to 90 Days Oldhttps://reachmd.com/news/variation-in-evaluation-and-management-of-febrile-infants-61-to-90-days-old/2487917/Key Takeaways Management patterns shifted over time, with less urine, blood, and cerebrospinal fluid testing, fewer hospitalizations and parenteral antibiotics, and more respiratory viral testing and procalcitonin use. Hospital-level variation was subs